Visual Outcome of Systemic Corticosteroids Treatment in Non-Arteritic Anterior Ischemic Optic Neuropathy

To date non arteritic anterior ischemic optic neuropathy (NAION) which is the most common acute optic neuropathy after the age 50 still lacks a proven effective accepted therapy. Recently a large retrospective non-randomized study suggested that systemic corticosteroid therapy given during the acute phase of NAION significantly improved visual acuity (VA) and visual fields (VF). Our purpose was to evaluate the visual and anatomical outcome of oral corticosteroids treatment in patients with NAION.